Matthew Bui

3.8k total citations · 1 hit paper
42 papers, 2.9k citations indexed

About

Matthew Bui is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Matthew Bui has authored 42 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Matthew Bui's work include Renal cell carcinoma treatment (18 papers), Renal and related cancers (10 papers) and Cancer Genomics and Diagnostics (6 papers). Matthew Bui is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Renal and related cancers (10 papers) and Cancer Genomics and Diagnostics (6 papers). Matthew Bui collaborates with scholars based in United States, Australia and Canada. Matthew Bui's co-authors include Arie S. Belldegrun, Robert A. Figlin, Gary R. Whittaker, Ari Helenius, David B. Seligson, Allan J. Pantuck, Steve Horvath, Frederick J. Dorey, Ken‐ryu Han and Bradley C. Leibovich and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Matthew Bui

40 papers receiving 2.8k citations

Hit Papers

Carbonic anhydrase IX is an independent predictor of surv... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Bui United States 25 1.7k 1.6k 752 577 523 42 2.9k
Sung‐Hsin Kuo Taiwan 35 783 0.5× 1.5k 1.0× 683 0.9× 426 0.7× 1.2k 2.3× 231 4.3k
Ronald J. Cohen Australia 29 1.2k 0.7× 1.8k 1.1× 427 0.6× 312 0.5× 397 0.8× 81 2.8k
Joanna H. Tong Hong Kong 37 2.3k 1.4× 1.0k 0.6× 1.3k 1.8× 486 0.8× 1.3k 2.5× 62 4.4k
Antonio Cossu Italy 34 1.9k 1.2× 586 0.4× 979 1.3× 352 0.6× 1.8k 3.4× 195 4.0k
Stanley K. Liu Canada 35 1.7k 1.0× 821 0.5× 810 1.1× 258 0.4× 914 1.7× 135 4.1k
Helen Won United States 28 1.9k 1.2× 1.4k 0.9× 1.2k 1.6× 621 1.1× 1.8k 3.5× 61 4.1k
Michael A. den Bakker Netherlands 35 676 0.4× 1.0k 0.7× 311 0.4× 755 1.3× 1.1k 2.1× 109 3.2k
Birgit Luber Germany 29 1.4k 0.9× 557 0.4× 418 0.6× 412 0.7× 1.3k 2.5× 58 2.9k
A. John Iafrate United States 26 952 0.6× 869 0.6× 374 0.5× 250 0.4× 940 1.8× 54 2.7k
Arun Rajan United States 34 1.0k 0.6× 889 0.6× 302 0.4× 413 0.7× 1.7k 3.3× 136 3.8k

Countries citing papers authored by Matthew Bui

Since Specialization
Citations

This map shows the geographic impact of Matthew Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bui more than expected).

Fields of papers citing papers by Matthew Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bui. The network helps show where Matthew Bui may publish in the future.

Co-authorship network of co-authors of Matthew Bui

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Bui. A scholar is included among the top collaborators of Matthew Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Bui. Matthew Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Goulet, Marie-Line, Shauna Dauphinee, Kristine S. Louis, et al.. (2024). Abstract PR006: EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: Preclinical characterization and translation into the clinic. Clinical Cancer Research. 30(10_Supplement). PR006–PR006. 1 indexed citations
3.
4.
Glezerman, Ilya, Sean M. Devlin, Molly Maloy, et al.. (2017). Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants. Bone Marrow Transplantation. 52(5). 733–738. 13 indexed citations
5.
Shao, Chen, Chun‐Peng Liao, Peizhen Hu, et al.. (2014). Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer. PLoS ONE. 9(2). e88967–e88967. 44 indexed citations
6.
Breda, Alberto, Matthew Bui, Joseph C. Liao, & Peter G. Schulam. (2007). Association of Bowel Rest and Ketorolac Analgesia with Short Hospital Stay After Laparoscopic Donor Nephrectomy. Urology. 69(5). 828–831. 17 indexed citations
7.
Lam, John S., Oleg Shvarts, Jonathan Said, et al.. (2005). Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 103(12). 2517–2525. 123 indexed citations
8.
Bui, Matthew, Harri Visapää, David B. Seligson, et al.. (2004). PROGNOSTIC VALUE OF CARBONIC ANHYDRASE IX AND KI67 AS PREDICTORS OF SURVIVAL FOR RENAL CLEAR CELL CARCINOMA. The Journal of Urology. 171(6 Part 1). 2461–2466. 146 indexed citations
9.
Leibovich, Bradley C., Ken‐ryu Han, Matthew Bui, et al.. (2003). Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma. Cancer. 98(12). 2566–2575. 159 indexed citations
10.
Leibovich, Bradley C., Allan J. Pantuck, Matthew Bui, et al.. (2003). Current staging of renal cell carcinoma. Urologic Clinics of North America. 30(3). 481–497. 27 indexed citations
11.
Zisman, Amnon, Allan J. Pantuck, Matthew Bui, et al.. (2003). LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.. PubMed. 63(16). 4952–9. 13 indexed citations
12.
Bui, Matthew, David B. Seligson, Ken‐ryu Han, et al.. (2003). Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma. 9(2). 802–811. 9 indexed citations
13.
Han, Ken‐ryu, Allan J. Pantuck, Matthew Bui, et al.. (2003). Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 61(2). 314–319. 93 indexed citations
14.
Visapää, Harri, Matthew Bui, Yunda Huang, et al.. (2003). Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology. 61(4). 845–850. 89 indexed citations
15.
Bui, Matthew, Julie E. Myers, & Gary R. Whittaker. (2002). Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Research. 84(1-2). 37–44. 32 indexed citations
16.
Bui, Matthew, Amnon Zisman, Allan J. Pantuck, et al.. (2001). Prognostic factors and molecular markers for renal cell carcinoma. Expert Review of Anticancer Therapy. 1(4). 565–575. 24 indexed citations
17.
Bui, Matthew, Elizabeth Wills, Ari Helenius, & Gary R. Whittaker. (2000). Role of the Influenza Virus M1 Protein in Nuclear Export of Viral Ribonucleoproteins. Journal of Virology. 74(4). 1781–1786. 160 indexed citations
18.
Bui, Matthew & Robert E. Reiter. (1998). Stem Cell Genes in Androgen-independent Prostate Cancer. Cancer and Metastasis Reviews. 17(4). 391–399. 47 indexed citations
19.
Whittaker, Gary R., Matthew Bui, & Ari Helenius. (1996). The role of nuclear import and export in influenza virus infection. Trends in Cell Biology. 6(2). 67–71. 95 indexed citations
20.
Adkins, Gregory S., et al.. (1993). Calculation of the two-photon-annihilation contribution to the positronium hyperfine interval at ordermα6. Physical Review A. 47(4). 2640–2652. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026